share_log

NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate

NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate

NRX Pharmicals第一季度每股收益美元(0.74美元)未达到预期(0.37美元)
Benzinga ·  05/14 16:37

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.37) by 100 percent. This is a 53.75 percent increase over losses of $(1.60) per share from the same period last year.

NRX Pharmicals(纳斯达克股票代码:NRXP)公布的季度亏损为每股0.74美元,比分析师普遍预期的0.37美元(0.37美元)低100%。这比去年同期每股亏损1.60美元(1.60美元)增长了53.75%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发